- Home
- RFIL vs IXHL Comparison
RFIL vs IXHL Comparison
Compare RFIL & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- IXHL
- Stock Information
- Founded
- RFIL 1979
- IXHL 2001
- Country
- RFIL United States
- IXHL Australia
- Employees
- RFIL N/A
- IXHL N/A
- Industry
- RFIL Electrical Products
- IXHL
- Sector
- RFIL Technology
- IXHL
- Exchange
- RFIL Nasdaq
- IXHL Nasdaq
- Market Cap
- RFIL 42.4M
- IXHL 39.2M
- IPO Year
- RFIL N/A
- IXHL N/A
- Fundamental
- Price
- RFIL $3.75
- IXHL $2.05
- Analyst Decision
- RFIL Strong Buy
- IXHL
- Analyst Count
- RFIL 1
- IXHL 0
- Target Price
- RFIL $4.50
- IXHL N/A
- AVG Volume (30 Days)
- RFIL 8.6K
- IXHL 16.6K
- Earning Date
- RFIL 01-21-2025
- IXHL 11-14-2024
- Dividend Yield
- RFIL N/A
- IXHL N/A
- EPS Growth
- RFIL N/A
- IXHL N/A
- EPS
- RFIL N/A
- IXHL N/A
- Revenue
- RFIL $62,278,000.00
- IXHL $86,000.00
- Revenue This Year
- RFIL N/A
- IXHL N/A
- Revenue Next Year
- RFIL $8.38
- IXHL N/A
- P/E Ratio
- RFIL N/A
- IXHL N/A
- Revenue Growth
- RFIL N/A
- IXHL N/A
- 52 Week Low
- RFIL $2.61
- IXHL $1.50
- 52 Week High
- RFIL $4.65
- IXHL $8.47
- Technical
- Relative Strength Index (RSI)
- RFIL 34.00
- IXHL 49.68
- Support Level
- RFIL $4.07
- IXHL $1.60
- Resistance Level
- RFIL $4.39
- IXHL $1.94
- Average True Range (ATR)
- RFIL 0.16
- IXHL 0.08
- MACD
- RFIL -0.04
- IXHL 0.03
- Stochastic Oscillator
- RFIL 0.00
- IXHL 92.18
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.